1. A primer on cancer immunology and immunotherapy

   • Michael T. Lotze
   • Michael Papamichail

   Review 23 January 2004 Pages: 135 - 138

2. Identification of tumour antigens by serological analysis of cDNA expression cloning

   • Geng Li
   • Amanda Miles
   • Robert C Rees

   Review 13 January 2004 Pages: 139 - 143

3. Identification of tumor antigens as potential target antigens for immunotherapy by serological expression cloning

   • Dirk Jäger
   • Christian Taverna
   • Alexander Knuth

   Review 15 January 2004 Pages: 144 - 147

4. Tetraspanins connect several types of Ig proteins: IgM is a novel component of the tetraspanin web on B-lymphoid cells

   • François Le Naour
   • Stéphanie Charrin
   • Eric Rubinstein

   Review 17 January 2004 Pages: 148 - 152

   

5. Apoptosis pathways in cancer and cancer therapy

   • Klaus-Michael Debatin

   Review 29 January 2004 Pages: 153 - 159

6. The use of gene function to identify the rate-limiting steps controlling cell fate

   • Gwyn T. Williams
   • Farzin Farzaneh

   Review 13 January 2004 Pages: 160 - 165

   

7. Immunobiology of HER-2/neu oncoprotein and its potential application in cancer immunotherapy

   • Constantin N. Baxevanis
   • Panagiota A. Sotiropoulou
   • Michael Papamichail

   Review 18 December 2003 Pages: 166 - 175

8. Natural killer lymphocytes: biology, development, and function

   • Michael Papamichail
   • Sonia A. Perez
   • Constantin N. Baxevanis

   Review 18 December 2003 Pages: 176 - 186

9. The Tübingen approach: identification, selection, and validation of tumor-associated HLA peptides for cancer therapy

   • Harpreet Singh-Jasuja
   • Niels P. N. Emmerich
   • Hans-Georg Rammensee

   Review 31 January 2004 Pages: 187 - 195

   

10. Identification of tumor antigens and T-cell epitopes, and its clinical application

    • Annette Paschen
    • Stefan Eichmuller
    • Dirk Schadendorf

    Review 20 December 2003 Pages: 196 - 203

11. Immunological inhibition of carcinogenesis

    • Michela Spadaro
    • Stefania Lanzardo
    • Federica Cavallo

    Review 13 January 2004 Pages: 204 - 216

    

12. Recombinant immunotoxins and retargeted killer cells: employing engineered antibody fragments for tumor-specific targeting of cytotoxic effectors

    • Winfried Wels
    • Markus Biburger
    • Christoph Uherek

    Review 24 December 2003 Pages: 217 - 226

    

13. Heat shock proteins: biological functions and clinical application as personalized vaccines for human cancer

    • Chiara Castelli
    • Licia Rivoltini
    • Giorgio Parmiani

    Review 19 December 2003 Pages: 227 - 233

14. Exosome-based immunotherapy

    • Nathalie Chaput
    • Julien Taïeb
    • Laurence Zitvogel

    Review 16 January 2004 Pages: 234 - 239

    

15. Dendritic cell biology and cancer therapy

    • Theresa L. Whiteside
    • Christine Odoux

    Review 18 December 2003 Pages: 240 - 248

16. Monitoring tumor antigen specific T-cell responses in cancer patients and phase I clinical trials of peptide-based vaccination

    • Pedro Romero
    • Jean-Charles Cerottini
    • Daniel E. Speiser

    Review 24 December 2003 Pages: 249 - 255

17. Identifying biomarkers and surrogates of tumors (cancer biometrics): correlation with immunotherapies and immune cells

    • Michael T. Lotze
    • Robert C. Rees

    Review 21 January 2004 Pages: 256 - 261

18. Tumour escape: antitumour effectors too much of a good thing?

    • Graham Pawelec

    Review 18 December 2003 Pages: 262 - 274